Delivery Order SPE2DB24D2100-SPE2DB24FBAQP

Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $39K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $3,334.90 and an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,576.66 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, which has an ultimate completion date of March 21, 2024, is for the supply of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The $8,152.52 contract has an ultimate completion date of April 15, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,185,885 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The $9,554.11 contract has a completion date of December 28, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $4,666.54 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,235,362 units of NURTEC ODT 75 MG TABLET 8S medication. The $70,517.61 delivery order contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside. The contract is part...
The U.S. Defense Logistics Agency (DLA) awarded a $20,457.63 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $20,965.84 and a performance period through April 8, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, to provide NURTEC ODT 75 MG TABLET 8S. The contract has a ceiling value of $20,427.77 and a performance period ending on March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $11,829.95 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NURTEC ODT 75 MG TABLET 8S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBAQP
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,118,646 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has a ceiling value of $39,263.29 and a performance period through April 1, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this award.

Generated 6/28/24, 10:20 AM